Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 234 | 141 | 303 | 360 | 316 |
| Operating Income | -234 | -141 | -303 | -360 | -316 |
| Other Income | 1,023 | 1,614 | 3,876 | 709 | 2,047 |
| Pre-tax Income | 790 | 1,473 | 3,573 | 349 | 1,731 |
| Net Income Continuous | 790 | 1,473 | 3,573 | 349 | 1,731 |
| Net Income | $790 | $1,473 | $3,573 | $349 | $1,731 |
| EPS Basic Total Ops | 0.00 | 0.08 | 0.21 | 0.09 | 0.10 |
| EPS Basic Continuous Ops | 0.23 | 0.43 | 1.04 | 0.12 | 0.50 |
| EPS Diluted Total Ops | 0.00 | 0.08 | 0.21 | 0.09 | 0.10 |
| EPS Diluted Continuous Ops | 0.23 | 0.43 | 1.04 | 0.12 | 0.50 |
| EPS Diluted Before Non-Recurring Items | 0.06 | 0.09 | 0.21 | N/A | N/A |
| EBITDA(a) | $-234 | $-141 | $-303 | $-360 | $-316 |